Labor induction at 41+0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial

dc.contributor.authorPlace Katariina
dc.contributor.authorRahkonen Leena
dc.contributor.authorTekay Aydin
dc.contributor.authorVäyrynen Kirsi
dc.contributor.authorOrden Maija-Riitta
dc.contributor.authorVääräsmäki Marja
dc.contributor.authorUotila Jukka
dc.contributor.authorTihtonen Kati
dc.contributor.authorRinne Kirsi
dc.contributor.authorMäkikallio Kaarin
dc.contributor.authorHeinonen Seppo
dc.contributor.authorKruit Heidi
dc.contributor.organizationfi=synnytys- ja naistentautioppi|en=Obstetrics and Gynaecology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.74725736230
dc.converis.publication-id380944482
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/380944482
dc.date.accessioned2025-08-28T01:44:04Z
dc.date.available2025-08-28T01:44:04Z
dc.description.abstract<div><p><strong>Introduction: </strong>Neonatal and maternal risks increase in term pregnancy as gestational age advances and become increasingly evident post-term. Management practices of late- and post-term pregnancies vary, and the optimal time point for intervention by labor induction is yet to be determined.</p><p><strong>Material and methods: </strong>This randomized controlled trial of 381 nulliparous women with unripe cervices compared labor induction at 41<sup>+0</sup> gestational weeks (early induction) with expectant management and labor induction at 41<sup>+5</sup> to 42<sup>+1</sup> gestational weeks (expectant management). This multicenter study included all five university hospitals and the largest central hospital in Finland. The study period was 2018–2022. Participants were randomized to either early induction (48.8%, <em>n</em> = 186) or expectant management (51.2%, <em>n</em> = 195) with equal randomization ratios of 1:1. This was a superiority trial, and the primary outcomes were rates of cesarean section (CS) and composite of adverse neonatal outcomes. The trial was registered at the ISRCTN registry (ISRCTN83219789, https://doi.org/10.1186/ISRCTN83219789).<br></p><p><strong>Results: </strong>The rates of CS (16.7% [<em>n</em> = 31] vs. 24.1% [<em>n</em> = 47], RR 0.7 [95% CI: 0.5–1.0], <em>p</em> = 0.07) and a composite of adverse neonatal outcomes (9.7% [<em>n</em> = 18] vs. 14.4% [<em>n</em> = 28], RR 0.7 [95% CI: 0.4–1.2] <em>p</em> = 0.16) did not significantly differ between the groups, but the operative delivery rate was lower in the early induction group than in the expectant management group (30.6% [<em>n</em> = 57] vs. 45.6% [<em>n</em> = 89], <em>p</em> = 0.003). The rates of hemorrhage ≥1000 mL and neonatal weight ≥4000 g were also lower in the early induction group, as was the vacuum extraction rate in women with vaginal delivery. Of the women with expectant management, 45.6% (<em>n</em> = 89) had spontaneous onset of labor. No perinatal deaths occurred, but one case of eclampsia appeared in the expectant management group.</p><p><strong>Conclusions: </strong>Offering labor induction to nulliparous women at 41<sup>+0</sup> gestational weeks may decrease the probability of operative delivery, postpartum hemorrhage, and neonatal weight ≥4000 g. However, this study was underpowered to affirm the trends of rising rates of CS and adverse neonatal outcomes in the expectant management group. Thus, expectant management could remain an option for some, as one in two women with expectant management had a spontaneous onset of labor.<br></p></div>
dc.format.pagerange505
dc.format.pagerange511
dc.identifier.eissn1600-0412
dc.identifier.jour-issn0001-6349
dc.identifier.olddbid207977
dc.identifier.oldhandle10024/191004
dc.identifier.urihttps://www.utupub.fi/handle/11111/57381
dc.identifier.urlhttps://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.14755
dc.identifier.urnURN:NBN:fi-fe2025082787833
dc.language.isoen
dc.okm.affiliatedauthorRinne, Kirsi
dc.okm.affiliatedauthorMäkikallio-Anttila, Kaarin
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3123 Gynaecology and paediatricsen_GB
dc.okm.discipline3123 Naisten- ja lastentauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherJohn Wiley & Sons
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1111/aogs.14755
dc.relation.ispartofjournalActa Obstetricia et Gynecologica Scandinavica
dc.relation.issue3
dc.relation.volume103
dc.source.identifierhttps://www.utupub.fi/handle/10024/191004
dc.titleLabor induction at 41+0 gestational weeks or expectant management for the nulliparous woman: The Finnish randomized controlled multicenter trial
dc.year.issued2024

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Acta Obstet Gynecol Scand - 2023 - Place - Labor induction at 41 0 gestational weeks or expectant management for the.pdf
Size:
735.41 KB
Format:
Adobe Portable Document Format